 in other areas that may affect your business, such as trading standards and fire safety.
We charge for Primary Authority work on a cost recovery basis at a rate of £70 per hour.
Before finalising any agreement, we will spend time with you to find out what level of support your business needs.
preparation of an action plan if appropriate.
Any surplus of the initial fee will be credited to your business for the provision of advice and support.
You can contact to discuss a Primary Authority Partnership using the details below.
Monday to Thursday: 8.45am to 5.15pm.
Friday: 8.45am to 4.45pm.I gave Nelson Mandela, Optimus, and The Monster a shot.  Freddy deserved a chance to get settled in Toronto.  I’m glad he came out and told us he feels settled here.  

His play certainly looks and feels different this year.  I completely understand what he meant when he wanted to make his movements more efficient - they’re subtle but it’s the calmness that Freddy is handling the puck from the first game of the preseason to the first game so far.

Andersen looks to be starting this season on a hot streak.Air ducts help heated or cooled air circulate throughout your home. Air ducts stabilize the room’s temperature; equally distributing the air in every room. However, the very things that the air ducts transfer are also the very things that can decrease air output flow and functionality.
When air moves, it is able to bring along particles that are light for them to carry. Particles such as dust, dirt, wood chippings, and the like, swirl and follow the direction of the wind and may end up accumulating in your air duct. Other particles and organisms (e.g mice, squirrels, and birds), that are too big for the air to carry, are also capable of entering and permanently living in your air ducts.
In order for your air duct to remain in tiptop condition, it must be cleaned, inspected, and maintained in a regular fashion.
There are two approaches to cleaning your air ducts. Now, depending on the situation you are facing, one method might be better than the other.
If your air ducts need minimal cleaning, then doing it by yourself is an acceptable choice. Hiring professionals for easy-to-do jobs is costly and unnecessary. Here are a few things you can do at home to keep your air ducts from wearing out.
Turn off the system first before working. You don’t want to damage the air ducts or be greeted with a surprise breeze of hot or cool air while working.
Remove and clean the dust covers or air grille plates. Wiping the covers will ensure that once you are done cleaning, it will be easier for air to enter your air duct systems.
Use your vacuum cleaner when cleaning your air ducts. Using a damp towel is difficult and time consuming. Your vacuum should be long enough to reach the duct’s inner casing. 
Emergency situations such as mold contamination, vermin infestation, and impossible cleans, are moments that should be handled by the professionals. Professional companies are equipped to deal with these types of events and have enough experience to handle these situations with care. If you decide to face these situations by yourself, you are putting yourself in harm’s way. You are prone to using incorrect methods, there is a higher chance that you are going to injure yourself, and your methods may make the situation much worse than it already is.
By choosing the right method, your air ducts will last longer and improve in functionality with each clean.
Here at All American Cleaning & Restoration, we offer our cleaning services to both residential and commercial areas in Southeast Idaho. Our professional team of cleaners, restorers, and repairers, know how to handle every situation in any given space; putting your property in great hands.
We specialize in cleaning air ducts, mold remediation, and many other cleaning related services. Call: |||PHONE_NUMBER|||  or visit our contact page for a FREE estimation or inspection today!Biotech drugs are a quickly growing component of health plan budgets. Here are the latest management techniques.
Seven years ago, Genentech made a clinical breakthrough when it gained approval for the breast cancer drug Herceptin. The biotech drug, a powerful protein inhibitor that has improved survival rates for women facing HER2-positive metastatic breast cancer, a particularly lethal form, offered a clear therapeutic benefit in the face of death. But that's not all that made Herceptin special: It also cost $20,000 a year — a record sum at the time.
But there isn't anything special about Herceptin's sticker price these days. Avastin, Gleevec, and Erbitux and others all followed, offering critical therapeutic advances and bearing ever-larger price tags.
Once only a blip on the radar screen of health care costs, specialty pharmaceutical prices have been racing ahead at nearly twice the rate of traditional pharmaceuticals. As the list grows, with hundreds more in the pipeline, managed care organizations have begun to organize specialty pharmacy programs to manage their use and to try to gain some measure of control over a budget item that is quickly gobbling up a growing chunk of health care expenses.
"To put it in perspective, we're in a health care cost crisis, and specialty pharmaceuticals are certainly a key piece of that," says Stan Borg, MD, chief medical officer of Blue Cross Blue Shield of Illinois.
Specialty pharmaceuticals now account for about 5 percent of overall drug costs, which account for 10 cents of every health dollar, says Randy Vogenberg, an analyst and senior vice president at Aon Consulting's life sciences division. That's less than a penny on every health care dollar — today.
"For specialty drugs," says Vogenberg, "it's all going up."
By Vogenberg's calculations, specialty pharmacy costs are escalating at 22.5 percent per year, leaving the general pharmacy price hikes of 13.1 percent far behind. New biotech drugs that often require special handling have been rolled out for rheumatoid arthritis, cancer, multiple sclerosis, and other chronic ailments at a cost that can range from $10,000 to $250,000 a year.
Utilization is shooting up as well. In a new study sponsored by the Blue Cross and Blue Shield Foundation on Health Care, the 17.8 million people in 10 Blues plans recorded a 12.1 percent increase in the use of these drugs over 2002 and 2003, helping make specialty pharmaceuticals the fastest growing element in the plans' drug budgets. And with another 800 specialty drugs in clinical development, says Vogenberg, specialty drugs are likely to eventually have a strong impact on any efforts to keep pharma costs under control.
"If we look at the pipeline for biotech," says Vogenberg, "it's huge, and it is going to start hitting from now on: Over the next five years there's a huge potential increase every year."
Aetna's response was to strike up a joint venture last year with the specialty distributor Priority Healthcare, creating Aetna Specialty Pharmacy in a bid to gain better control over a specialty pharma tab that had broken the $1 billion mark. PBMs have been pushing consolidation, with two new deals in the works: Express Scripts's purchase of Priority and Medco Health Solutions's acquisition of Accredo Health. CaremarkRx and McKesson have each built their own specialty divisions, says Murray, and many stand-alone specialty drug groups still offer varying strategies for managing the benefit.
The consolidation of specialty pharma is being driven by a much greater focus on specialty drugs overall as new drugs are approved, says Murray, who helped launch PCMA's Specialty Pharmaceutical Council earlier this year to shepherd the industry's policy positions and lobbying efforts. Mainstream drug developers have been buying up specialty products in the pipeline to add to their own lineup of future offerings, and payers can see that a wave of specialty drugs will call for a much different method for managing them.
"They'll be looking to see who can manage these drugs, to distribute them," says Vogenberg. "They aren't going to the retail counter to get them. What you'll see over time is continued consolidation, with payers saying, 'How do we get the drug benefit in toto under one roof.' "
"These are high-touch, complex drugs with very specific methods of delivery, often with injection and infusion," says Murray. "They often require other care — a caseworker or nurse assigned to a patient — with 24/7 access to telephone help lines. It's created a whole industry not only in charge of getting a drug to a patient but then also all the other ancillary services needed to make sure the patient is staying on the drug."
"Nobody has the solution right now, but people are aware that they have to start looking at this," says Vogenberg.
In part, that's because managed care's biggest clients are telling them to, and are not trying to figure out ways to deny their workers these drugs or to make them bear most of the costs. In some cases, says Vogenberg, companies such as Pitney Bowes have decided that making sure their chronically ill workers have access to the newest biotech drugs offers them a solid payback in the forms of fewer acute cases, fewer hospitalizations, and fewer lost days of work.
To truly manage specialty drugs, a plan needs to have a comprehensive approach that works for the best price that the market allows and ensures that the right drugs are used by the people who need them in the way that they are prescribed. Preauthorization can be useful.
Any member of the Illinois Blues plan that requests a